Bernard Denoyer - Net Worth and Insider Trading
Bernard Denoyer Net Worth
The estimated net worth of Bernard Denoyer is at least $0 dollars as of 2024-11-29. Bernard Denoyer is the Senior Vice President, Finance of Synergy Pharmaceuticals Inc and owns about 0 shares of Synergy Pharmaceuticals Inc (SGYPQ) stock worth over $0. Details can be seen in Bernard Denoyer's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Bernard Denoyer has not made any transactions after 2015-09-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Bernard Denoyer
Bernard Denoyer Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Bernard Denoyer owns 3 companies in total, including Synergy Pharmaceuticals Inc (SGYPQ) , Hepion Pharmaceuticals Inc (HEPA) , and OKYO Pharma Ltd (OKYO) .
Click here to see the complete history of Bernard Denoyer’s form 4 insider trades.
Insider Ownership Summary of Bernard Denoyer
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SGYPQ | Synergy Pharmaceuticals Inc | 2016-06-24 | Senior Vice President & Finance |
| HEPA | Hepion Pharmaceuticals Inc | 2013-10-07 | CFO and Secretary |
| OKYO | OKYO Pharma Ltd | 2022-05-16 | director |
Bernard Denoyer Latest Holdings Summary
Bernard Denoyer currently owns a total of 1 stock. Bernard Denoyer owns 0 shares of Synergy Pharmaceuticals Inc (SGYPQ) as of September 14, 2015, with a value of $0.
Latest Holdings of Bernard Denoyer
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SGYPQ | Synergy Pharmaceuticals Inc | 2015-09-14 | 0 | 0.01 | 0 |
Holding Weightings of Bernard Denoyer
Bernard Denoyer Form 4 Trading Tracker
According to the SEC Form 4 filings, Bernard Denoyer has made a total of 0 transactions in Synergy Pharmaceuticals Inc (SGYPQ) over the past 5 years. The most-recent trade in Synergy Pharmaceuticals Inc is the sale of 10,000 shares on September 14, 2015, which brought Bernard Denoyer around $75,000.
Insider Trading History of Bernard Denoyer
- 1
Bernard Denoyer Trading Performance
GuruFocus tracks the stock performance after each of Bernard Denoyer's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Bernard Denoyer is -4.01%. GuruFocus also compares Bernard Denoyer's trading performance to market benchmark return within the same time period. The performance of stocks bought by Bernard Denoyer within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Bernard Denoyer's insider trading performs compared to the benchmark.
Performance of Bernard Denoyer
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.02 | | | | | |
| Relative Return to S&P 500(%) | -8.78 | | | | | |
Bernard Denoyer Ownership Network
Bernard Denoyer Owned Company Details
What does Synergy Pharmaceuticals Inc do?
Who are the key executives at Synergy Pharmaceuticals Inc?
Bernard Denoyer is the Senior Vice President & Finance of Synergy Pharmaceuticals Inc. Other key executives at Synergy Pharmaceuticals Inc include director & Executive Chairman Gary S Jacob , Executive Vice Pres. & CFO Gary G Gemignani , and 10 percent owner Paulson & Co. Inc. .
Synergy Pharmaceuticals Inc (SGYPQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Synergy Pharmaceuticals Inc (SGYPQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Synergy Pharmaceuticals Inc (SGYPQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Synergy Pharmaceuticals Inc (SGYPQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Synergy Pharmaceuticals Inc Insider Transactions
Bernard Denoyer Mailing Address
Above is the net worth, insider trading, and ownership report for Bernard Denoyer. You might contact Bernard Denoyer via mailing address: C/o Callisto Pharmaceuticals, Inc., 420 Lexington Avenue, Suite 1609, New York Ny 10170.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
